The bio-tech analyst predicted PPS of .20 when they reach revenue of 40 mil. in 2027. Heck we have seen this PPS few weeks ago. Now you know what analysis you would be getting out of diagnostics also. i.e 2% market share first year after approval and then will grow in multiples.. simple as that. But yes, diagnostics will move bit faster than MANF.
Market Data 
Markets
AI
